Infrared inspection tech to identify API errors

By Staff Reporter

- Last updated on GMT

(Image: Getty/Fahroni)
(Image: Getty/Fahroni)

Related tags Infrared Blister packs

SEA Vision says its HarleNir technology can identify errors on the manufacturing line, even if the product appears visually sound.

Last week, SEA Vision launched its Near Infrared Hyperspectral vision (NIR) system, the ‘HarleNir’. The technology is designed to ‘go beyond visible inspection’ when inspecting batches on the manufacturing line.

“Through integrated imaging technology, HarleNIR can distinguish products directly from their active ingredients and perform a chemical analysis to identify compounds with different active principle, different dosage or measure the active ingredient uniformity distribution inside products,”​ said business development manager, Paolo Landriani.

The news follows on from SEA Visions announcement​ in July this year, revealing plans to invest $1.5m (€1.3m) in new offices across the US, Germany, and Russia to meet demand for track and trace compliance technology.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...